MA1-90420, Invitrogen
A recent retrospective cohort also observed that, even in overweight patients without diabetes, the risk of primary open-angle glaucoma and ocular hypertension were significantly lower in the GLP-1RA group at both 3 and 5 years of follow-up (Vasu et al., 2025), suggesting the benefit of GLP-1RAs in the eye as an independent factor apart from blood glucose control
Keep watching the OFK Lab in the Institute of Biomedical Engineering at the University of Toronto to see whats next for this exciting therapeutic approach
Started low, no nausea, easy ramp up. Kira N
On social media, people report losing weight with tiny doses of GLP-1 medications like Ozempic, Wegovy, Mounjaro or Zepbound
A POTS patient who needed to take 2-3 times more time to get her college work done, reported she no longer had brain fog and was able to do her work in a third of the time